nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A4—type 2 diabetes mellitus	0.237	1	CbGaD
Vardenafil—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0462	0.146	CbGbCtD
Vardenafil—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0369	0.116	CbGbCtD
Vardenafil—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0329	0.104	CbGbCtD
Vardenafil—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0301	0.0949	CbGbCtD
Vardenafil—CYP3A5—Losartan—type 2 diabetes mellitus	0.0286	0.0901	CbGbCtD
Vardenafil—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0263	0.083	CbGbCtD
Vardenafil—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0238	0.075	CbGbCtD
Vardenafil—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.018	0.0569	CbGbCtD
Vardenafil—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0173	0.0545	CbGbCtD
Vardenafil—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0173	0.0545	CbGbCtD
Vardenafil—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0163	0.0515	CbGbCtD
Vardenafil—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0122	0.0384	CbGbCtD
Vardenafil—CYP3A4—Losartan—type 2 diabetes mellitus	0.0111	0.0351	CbGbCtD
Vardenafil—PDE5A—penis—type 2 diabetes mellitus	0.00904	0.193	CbGeAlD
Vardenafil—PDE6H—retina—type 2 diabetes mellitus	0.00452	0.0967	CbGeAlD
Vardenafil—PDE6G—retina—type 2 diabetes mellitus	0.00435	0.093	CbGeAlD
Vardenafil—PDE5A—artery—type 2 diabetes mellitus	0.00418	0.0895	CbGeAlD
Vardenafil—PDE5A—endothelium—type 2 diabetes mellitus	0.00353	0.0756	CbGeAlD
Vardenafil—PDE10A—nephron tubule—type 2 diabetes mellitus	0.00277	0.0592	CbGeAlD
Vardenafil—PDE11A—liver—type 2 diabetes mellitus	0.00236	0.0506	CbGeAlD
Vardenafil—PDE6G—liver—type 2 diabetes mellitus	0.00227	0.0487	CbGeAlD
Vardenafil—PDE10A—adipose tissue—type 2 diabetes mellitus	0.00219	0.0469	CbGeAlD
Vardenafil—PDE1B—adipose tissue—type 2 diabetes mellitus	0.00217	0.0465	CbGeAlD
Vardenafil—PDE5A—retina—type 2 diabetes mellitus	0.00172	0.0368	CbGeAlD
Vardenafil—Udenafil—CYP3A4—type 2 diabetes mellitus	0.00147	0.436	CrCbGaD
Vardenafil—PDE5A—cardiovascular system—type 2 diabetes mellitus	0.00145	0.0311	CbGeAlD
Vardenafil—PDE5A—adipose tissue—type 2 diabetes mellitus	0.00128	0.0274	CbGeAlD
Vardenafil—Sildenafil—CYP2E1—type 2 diabetes mellitus	0.00116	0.346	CrCbGaD
Vardenafil—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000835	0.0179	CbGeAlD
Vardenafil—Sildenafil—CYP3A4—type 2 diabetes mellitus	0.000732	0.218	CrCbGaD
Vardenafil—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000672	0.0144	CbGeAlD
Vardenafil—CYP3A5—kidney—type 2 diabetes mellitus	0.000591	0.0126	CbGeAlD
Vardenafil—CYP3A5—pancreas—type 2 diabetes mellitus	0.000587	0.0126	CbGeAlD
Vardenafil—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000576	0.0123	CbGeAlD
Vardenafil—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000533	0.0114	CbGeAlD
Vardenafil—CYP3A4—kidney—type 2 diabetes mellitus	0.000443	0.00949	CbGeAlD
Vardenafil—CYP3A5—liver—type 2 diabetes mellitus	0.000374	0.00799	CbGeAlD
Vardenafil—CYP3A4—liver—type 2 diabetes mellitus	0.00028	0.006	CbGeAlD
Vardenafil—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000162	0.00064	CcSEcCtD
Vardenafil—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000161	0.000636	CcSEcCtD
Vardenafil—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00016	0.000635	CcSEcCtD
Vardenafil—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.00016	0.000634	CcSEcCtD
Vardenafil—Back pain—Losartan—type 2 diabetes mellitus	0.00016	0.000634	CcSEcCtD
Vardenafil—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00016	0.000634	CcSEcCtD
Vardenafil—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00016	0.000633	CcSEcCtD
Vardenafil—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00016	0.000632	CcSEcCtD
Vardenafil—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000159	0.00063	CcSEcCtD
Vardenafil—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000159	0.000629	CcSEcCtD
Vardenafil—Chest pain—Metformin—type 2 diabetes mellitus	0.000159	0.000628	CcSEcCtD
Vardenafil—Myalgia—Metformin—type 2 diabetes mellitus	0.000159	0.000628	CcSEcCtD
Vardenafil—Malaise—Irbesartan—type 2 diabetes mellitus	0.000159	0.000628	CcSEcCtD
Vardenafil—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000158	0.000625	CcSEcCtD
Vardenafil—Headache—Pioglitazone—type 2 diabetes mellitus	0.000158	0.000625	CcSEcCtD
Vardenafil—Syncope—Irbesartan—type 2 diabetes mellitus	0.000158	0.000624	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000158	0.000624	CcSEcCtD
Vardenafil—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000157	0.000622	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000157	0.000621	CcSEcCtD
Vardenafil—Discomfort—Metformin—type 2 diabetes mellitus	0.000157	0.000621	CcSEcCtD
Vardenafil—Nausea—Glipizide—type 2 diabetes mellitus	0.000156	0.000619	CcSEcCtD
Vardenafil—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000156	0.000618	CcSEcCtD
Vardenafil—Hypotension—Valsartan—type 2 diabetes mellitus	0.000156	0.000618	CcSEcCtD
Vardenafil—Vision blurred—Losartan—type 2 diabetes mellitus	0.000156	0.000617	CcSEcCtD
Vardenafil—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000156	0.000616	CcSEcCtD
Vardenafil—Pain—Gliclazide—type 2 diabetes mellitus	0.000156	0.000615	CcSEcCtD
Vardenafil—Rash—Glimepiride—type 2 diabetes mellitus	0.000155	0.000613	CcSEcCtD
Vardenafil—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000155	0.000612	CcSEcCtD
Vardenafil—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000155	0.000612	CcSEcCtD
Vardenafil—Rash—Sitagliptin—type 2 diabetes mellitus	0.000154	0.000611	CcSEcCtD
Vardenafil—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000154	0.00061	CcSEcCtD
Vardenafil—Headache—Glimepiride—type 2 diabetes mellitus	0.000154	0.000609	CcSEcCtD
Vardenafil—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000154	0.000608	CcSEcCtD
Vardenafil—Headache—Sitagliptin—type 2 diabetes mellitus	0.000153	0.000607	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000152	0.000602	CcSEcCtD
Vardenafil—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000152	0.000602	CcSEcCtD
Vardenafil—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000152	0.0006	CcSEcCtD
Vardenafil—Flushing—Ramipril—type 2 diabetes mellitus	0.000151	0.000599	CcSEcCtD
Vardenafil—Angioedema—Losartan—type 2 diabetes mellitus	0.000151	0.000599	CcSEcCtD
Vardenafil—Infection—Metformin—type 2 diabetes mellitus	0.000151	0.000598	CcSEcCtD
Vardenafil—Insomnia—Valsartan—type 2 diabetes mellitus	0.000151	0.000598	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000151	0.000595	CcSEcCtD
Vardenafil—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00015	0.000594	CcSEcCtD
Vardenafil—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00015	0.000593	CcSEcCtD
Vardenafil—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.00015	0.000593	CcSEcCtD
Vardenafil—Myalgia—Irbesartan—type 2 diabetes mellitus	0.00015	0.000593	CcSEcCtD
Vardenafil—Chest pain—Irbesartan—type 2 diabetes mellitus	0.00015	0.000593	CcSEcCtD
Vardenafil—Shock—Metformin—type 2 diabetes mellitus	0.00015	0.000592	CcSEcCtD
Vardenafil—Insomnia—Orlistat—type 2 diabetes mellitus	0.000149	0.000591	CcSEcCtD
Vardenafil—Malaise—Losartan—type 2 diabetes mellitus	0.000149	0.000591	CcSEcCtD
Vardenafil—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000149	0.000591	CcSEcCtD
Vardenafil—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000149	0.00059	CcSEcCtD
Vardenafil—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000149	0.00059	CcSEcCtD
Vardenafil—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000149	0.000589	CcSEcCtD
Vardenafil—Vertigo—Losartan—type 2 diabetes mellitus	0.000149	0.000589	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000149	0.000589	CcSEcCtD
Vardenafil—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000149	0.000588	CcSEcCtD
Vardenafil—Somnolence—Valsartan—type 2 diabetes mellitus	0.000149	0.000588	CcSEcCtD
Vardenafil—Syncope—Losartan—type 2 diabetes mellitus	0.000149	0.000588	CcSEcCtD
Vardenafil—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000148	0.000587	CcSEcCtD
Vardenafil—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000148	0.000586	CcSEcCtD
Vardenafil—Skin disorder—Metformin—type 2 diabetes mellitus	0.000148	0.000585	CcSEcCtD
Vardenafil—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000147	0.000583	CcSEcCtD
Vardenafil—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000147	0.000582	CcSEcCtD
Vardenafil—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000147	0.000582	CcSEcCtD
Vardenafil—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000147	0.000582	CcSEcCtD
Vardenafil—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000147	0.00058	CcSEcCtD
Vardenafil—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000147	0.00058	CcSEcCtD
Vardenafil—Palpitations—Losartan—type 2 diabetes mellitus	0.000146	0.000579	CcSEcCtD
Vardenafil—Nausea—Glimepiride—type 2 diabetes mellitus	0.000146	0.000577	CcSEcCtD
Vardenafil—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000146	0.000576	CcSEcCtD
Vardenafil—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000146	0.000575	CcSEcCtD
Vardenafil—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000145	0.000575	CcSEcCtD
Vardenafil—Asthenia—Glyburide—type 2 diabetes mellitus	0.000145	0.000575	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000144	0.000571	CcSEcCtD
Vardenafil—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000144	0.000569	CcSEcCtD
Vardenafil—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000144	0.000568	CcSEcCtD
Vardenafil—Pruritus—Glyburide—type 2 diabetes mellitus	0.000143	0.000567	CcSEcCtD
Vardenafil—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000143	0.000565	CcSEcCtD
Vardenafil—Infection—Irbesartan—type 2 diabetes mellitus	0.000143	0.000564	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000143	0.000564	CcSEcCtD
Vardenafil—Hypotension—Metformin—type 2 diabetes mellitus	0.000142	0.000563	CcSEcCtD
Vardenafil—Erythema—Ramipril—type 2 diabetes mellitus	0.000142	0.000562	CcSEcCtD
Vardenafil—Shock—Irbesartan—type 2 diabetes mellitus	0.000141	0.000559	CcSEcCtD
Vardenafil—Pain—Orlistat—type 2 diabetes mellitus	0.000141	0.000559	CcSEcCtD
Vardenafil—Chest pain—Losartan—type 2 diabetes mellitus	0.000141	0.000558	CcSEcCtD
Vardenafil—Arthralgia—Losartan—type 2 diabetes mellitus	0.000141	0.000558	CcSEcCtD
Vardenafil—Myalgia—Losartan—type 2 diabetes mellitus	0.000141	0.000558	CcSEcCtD
Vardenafil—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000141	0.000557	CcSEcCtD
Vardenafil—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000141	0.000557	CcSEcCtD
Vardenafil—Anxiety—Losartan—type 2 diabetes mellitus	0.000141	0.000556	CcSEcCtD
Vardenafil—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00014	0.000555	CcSEcCtD
Vardenafil—Rash—Bromocriptine—type 2 diabetes mellitus	0.00014	0.000553	CcSEcCtD
Vardenafil—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00014	0.000552	CcSEcCtD
Vardenafil—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00014	0.000552	CcSEcCtD
Vardenafil—Discomfort—Losartan—type 2 diabetes mellitus	0.000139	0.000551	CcSEcCtD
Vardenafil—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000139	0.000549	CcSEcCtD
Vardenafil—Headache—Bromocriptine—type 2 diabetes mellitus	0.000139	0.000549	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000139	0.000549	CcSEcCtD
Vardenafil—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000139	0.000548	CcSEcCtD
Vardenafil—Dry mouth—Losartan—type 2 diabetes mellitus	0.000138	0.000546	CcSEcCtD
Vardenafil—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000137	0.000541	CcSEcCtD
Vardenafil—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000137	0.000541	CcSEcCtD
Vardenafil—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000137	0.00054	CcSEcCtD
Vardenafil—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000136	0.000538	CcSEcCtD
Vardenafil—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000136	0.000537	CcSEcCtD
Vardenafil—Somnolence—Metformin—type 2 diabetes mellitus	0.000135	0.000535	CcSEcCtD
Vardenafil—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000135	0.000535	CcSEcCtD
Vardenafil—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000135	0.000534	CcSEcCtD
Vardenafil—Infection—Losartan—type 2 diabetes mellitus	0.000134	0.000531	CcSEcCtD
Vardenafil—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000134	0.000531	CcSEcCtD
Vardenafil—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000134	0.00053	CcSEcCtD
Vardenafil—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000134	0.00053	CcSEcCtD
Vardenafil—Shock—Losartan—type 2 diabetes mellitus	0.000133	0.000526	CcSEcCtD
Vardenafil—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000133	0.000524	CcSEcCtD
Vardenafil—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000132	0.000523	CcSEcCtD
Vardenafil—Tachycardia—Losartan—type 2 diabetes mellitus	0.000132	0.000522	CcSEcCtD
Vardenafil—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000132	0.000521	CcSEcCtD
Vardenafil—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000132	0.000521	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000131	0.00052	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000131	0.000518	CcSEcCtD
Vardenafil—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000131	0.000517	CcSEcCtD
Vardenafil—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000131	0.000516	CcSEcCtD
Vardenafil—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000131	0.000516	CcSEcCtD
Vardenafil—Angioedema—Ramipril—type 2 diabetes mellitus	0.00013	0.000513	CcSEcCtD
Vardenafil—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000129	0.00051	CcSEcCtD
Vardenafil—Vomiting—Glyburide—type 2 diabetes mellitus	0.000129	0.00051	CcSEcCtD
Vardenafil—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000129	0.000509	CcSEcCtD
Vardenafil—Malaise—Ramipril—type 2 diabetes mellitus	0.000128	0.000507	CcSEcCtD
Vardenafil—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000128	0.000507	CcSEcCtD
Vardenafil—Rash—Glyburide—type 2 diabetes mellitus	0.000128	0.000505	CcSEcCtD
Vardenafil—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000128	0.000505	CcSEcCtD
Vardenafil—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000128	0.000505	CcSEcCtD
Vardenafil—Vertigo—Ramipril—type 2 diabetes mellitus	0.000128	0.000505	CcSEcCtD
Vardenafil—Syncope—Ramipril—type 2 diabetes mellitus	0.000127	0.000504	CcSEcCtD
Vardenafil—Headache—Glyburide—type 2 diabetes mellitus	0.000127	0.000502	CcSEcCtD
Vardenafil—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000126	0.0005	CcSEcCtD
Vardenafil—Hypotension—Losartan—type 2 diabetes mellitus	0.000126	0.0005	CcSEcCtD
Vardenafil—Palpitations—Ramipril—type 2 diabetes mellitus	0.000126	0.000496	CcSEcCtD
Vardenafil—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000125	0.000496	CcSEcCtD
Vardenafil—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000125	0.000494	CcSEcCtD
Vardenafil—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000125	0.000492	CcSEcCtD
Vardenafil—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000125	0.000492	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000124	0.000491	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000123	0.000487	CcSEcCtD
Vardenafil—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000123	0.000487	CcSEcCtD
Vardenafil—Convulsion—Ramipril—type 2 diabetes mellitus	0.000123	0.000487	CcSEcCtD
Vardenafil—Pain—Irbesartan—type 2 diabetes mellitus	0.000123	0.000486	CcSEcCtD
Vardenafil—Insomnia—Losartan—type 2 diabetes mellitus	0.000122	0.000484	CcSEcCtD
Vardenafil—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000122	0.000481	CcSEcCtD
Vardenafil—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000121	0.00048	CcSEcCtD
Vardenafil—Chest pain—Ramipril—type 2 diabetes mellitus	0.000121	0.000478	CcSEcCtD
Vardenafil—Myalgia—Ramipril—type 2 diabetes mellitus	0.000121	0.000478	CcSEcCtD
Vardenafil—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000121	0.000478	CcSEcCtD
Vardenafil—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000121	0.000477	CcSEcCtD
Vardenafil—Anxiety—Ramipril—type 2 diabetes mellitus	0.000121	0.000477	CcSEcCtD
Vardenafil—Nausea—Glyburide—type 2 diabetes mellitus	0.00012	0.000476	CcSEcCtD
Vardenafil—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00012	0.000476	CcSEcCtD
Vardenafil—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00012	0.000476	CcSEcCtD
Vardenafil—Somnolence—Losartan—type 2 diabetes mellitus	0.00012	0.000475	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.00012	0.000475	CcSEcCtD
Vardenafil—Asthenia—Valsartan—type 2 diabetes mellitus	0.00012	0.000474	CcSEcCtD
Vardenafil—Discomfort—Ramipril—type 2 diabetes mellitus	0.000119	0.000473	CcSEcCtD
Vardenafil—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000119	0.000471	CcSEcCtD
Vardenafil—Asthenia—Orlistat—type 2 diabetes mellitus	0.000119	0.000469	CcSEcCtD
Vardenafil—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000118	0.000468	CcSEcCtD
Vardenafil—Pruritus—Valsartan—type 2 diabetes mellitus	0.000118	0.000468	CcSEcCtD
Vardenafil—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000118	0.000468	CcSEcCtD
Vardenafil—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000117	0.000465	CcSEcCtD
Vardenafil—Pruritus—Orlistat—type 2 diabetes mellitus	0.000117	0.000462	CcSEcCtD
Vardenafil—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000116	0.000458	CcSEcCtD
Vardenafil—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000116	0.000458	CcSEcCtD
Vardenafil—Pain—Losartan—type 2 diabetes mellitus	0.000116	0.000457	CcSEcCtD
Vardenafil—Rash—Gliclazide—type 2 diabetes mellitus	0.000115	0.000454	CcSEcCtD
Vardenafil—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000115	0.000453	CcSEcCtD
Vardenafil—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000114	0.000452	CcSEcCtD
Vardenafil—Shock—Ramipril—type 2 diabetes mellitus	0.000114	0.000451	CcSEcCtD
Vardenafil—Headache—Gliclazide—type 2 diabetes mellitus	0.000114	0.000451	CcSEcCtD
Vardenafil—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000114	0.00045	CcSEcCtD
Vardenafil—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000114	0.000449	CcSEcCtD
Vardenafil—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000113	0.000447	CcSEcCtD
Vardenafil—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000113	0.000447	CcSEcCtD
Vardenafil—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000113	0.000445	CcSEcCtD
Vardenafil—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000112	0.000443	CcSEcCtD
Vardenafil—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000111	0.000441	CcSEcCtD
Vardenafil—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000111	0.000437	CcSEcCtD
Vardenafil—Dizziness—Valsartan—type 2 diabetes mellitus	0.000111	0.000437	CcSEcCtD
Vardenafil—Dizziness—Orlistat—type 2 diabetes mellitus	0.000109	0.000432	CcSEcCtD
Vardenafil—Asthenia—Metformin—type 2 diabetes mellitus	0.000109	0.000432	CcSEcCtD
Vardenafil—Hypotension—Ramipril—type 2 diabetes mellitus	0.000108	0.000428	CcSEcCtD
Vardenafil—Nausea—Gliclazide—type 2 diabetes mellitus	0.000108	0.000427	CcSEcCtD
Vardenafil—Pruritus—Metformin—type 2 diabetes mellitus	0.000108	0.000426	CcSEcCtD
Vardenafil—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000107	0.000423	CcSEcCtD
Vardenafil—Vomiting—Valsartan—type 2 diabetes mellitus	0.000106	0.00042	CcSEcCtD
Vardenafil—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000106	0.000419	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000106	0.000418	CcSEcCtD
Vardenafil—Rash—Valsartan—type 2 diabetes mellitus	0.000105	0.000417	CcSEcCtD
Vardenafil—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000105	0.000416	CcSEcCtD
Vardenafil—Vomiting—Orlistat—type 2 diabetes mellitus	0.000105	0.000415	CcSEcCtD
Vardenafil—Insomnia—Ramipril—type 2 diabetes mellitus	0.000105	0.000415	CcSEcCtD
Vardenafil—Headache—Valsartan—type 2 diabetes mellitus	0.000105	0.000414	CcSEcCtD
Vardenafil—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000104	0.000412	CcSEcCtD
Vardenafil—Rash—Orlistat—type 2 diabetes mellitus	0.000104	0.000412	CcSEcCtD
Vardenafil—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000104	0.000412	CcSEcCtD
Vardenafil—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000104	0.000412	CcSEcCtD
Vardenafil—Headache—Orlistat—type 2 diabetes mellitus	0.000103	0.000409	CcSEcCtD
Vardenafil—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000103	0.000409	CcSEcCtD
Vardenafil—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000103	0.000408	CcSEcCtD
Vardenafil—Somnolence—Ramipril—type 2 diabetes mellitus	0.000103	0.000408	CcSEcCtD
Vardenafil—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000102	0.000404	CcSEcCtD
Vardenafil—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000102	0.000402	CcSEcCtD
Vardenafil—Dizziness—Metformin—type 2 diabetes mellitus	0.000101	0.000398	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.0001	0.000396	CcSEcCtD
Vardenafil—Hypersensitivity—Losartan—type 2 diabetes mellitus	9.96e-05	0.000394	CcSEcCtD
Vardenafil—Nausea—Valsartan—type 2 diabetes mellitus	9.93e-05	0.000393	CcSEcCtD
Vardenafil—Diarrhoea—Irbesartan—type 2 diabetes mellitus	9.83e-05	0.000389	CcSEcCtD
Vardenafil—Nausea—Orlistat—type 2 diabetes mellitus	9.81e-05	0.000388	CcSEcCtD
Vardenafil—Asthenia—Losartan—type 2 diabetes mellitus	9.7e-05	0.000384	CcSEcCtD
Vardenafil—Vomiting—Metformin—type 2 diabetes mellitus	9.68e-05	0.000383	CcSEcCtD
Vardenafil—Rash—Metformin—type 2 diabetes mellitus	9.6e-05	0.00038	CcSEcCtD
Vardenafil—Dermatitis—Metformin—type 2 diabetes mellitus	9.59e-05	0.000379	CcSEcCtD
Vardenafil—Pruritus—Losartan—type 2 diabetes mellitus	9.57e-05	0.000378	CcSEcCtD
Vardenafil—Feeling abnormal—Ramipril—type 2 diabetes mellitus	9.55e-05	0.000378	CcSEcCtD
Vardenafil—Headache—Metformin—type 2 diabetes mellitus	9.54e-05	0.000377	CcSEcCtD
Vardenafil—Dizziness—Irbesartan—type 2 diabetes mellitus	9.5e-05	0.000376	CcSEcCtD
Vardenafil—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	9.48e-05	0.000375	CcSEcCtD
Vardenafil—Diarrhoea—Losartan—type 2 diabetes mellitus	9.25e-05	0.000366	CcSEcCtD
Vardenafil—Abdominal pain—Ramipril—type 2 diabetes mellitus	9.17e-05	0.000362	CcSEcCtD
Vardenafil—Vomiting—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000361	CcSEcCtD
Vardenafil—Rash—Irbesartan—type 2 diabetes mellitus	9.06e-05	0.000358	CcSEcCtD
Vardenafil—Dermatitis—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.000358	CcSEcCtD
Vardenafil—Nausea—Metformin—type 2 diabetes mellitus	9.04e-05	0.000358	CcSEcCtD
Vardenafil—Headache—Irbesartan—type 2 diabetes mellitus	9e-05	0.000356	CcSEcCtD
Vardenafil—Dizziness—Losartan—type 2 diabetes mellitus	8.94e-05	0.000354	CcSEcCtD
Vardenafil—Vomiting—Losartan—type 2 diabetes mellitus	8.6e-05	0.00034	CcSEcCtD
Vardenafil—Hypersensitivity—Ramipril—type 2 diabetes mellitus	8.54e-05	0.000338	CcSEcCtD
Vardenafil—Nausea—Irbesartan—type 2 diabetes mellitus	8.53e-05	0.000337	CcSEcCtD
Vardenafil—Rash—Losartan—type 2 diabetes mellitus	8.53e-05	0.000337	CcSEcCtD
Vardenafil—Dermatitis—Losartan—type 2 diabetes mellitus	8.52e-05	0.000337	CcSEcCtD
Vardenafil—Headache—Losartan—type 2 diabetes mellitus	8.47e-05	0.000335	CcSEcCtD
Vardenafil—Asthenia—Ramipril—type 2 diabetes mellitus	8.32e-05	0.000329	CcSEcCtD
Vardenafil—Pruritus—Ramipril—type 2 diabetes mellitus	8.2e-05	0.000324	CcSEcCtD
Vardenafil—Nausea—Losartan—type 2 diabetes mellitus	8.03e-05	0.000318	CcSEcCtD
Vardenafil—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.93e-05	0.000314	CcSEcCtD
Vardenafil—Dizziness—Ramipril—type 2 diabetes mellitus	7.67e-05	0.000303	CcSEcCtD
Vardenafil—Vomiting—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000292	CcSEcCtD
Vardenafil—Rash—Ramipril—type 2 diabetes mellitus	7.31e-05	0.000289	CcSEcCtD
Vardenafil—Dermatitis—Ramipril—type 2 diabetes mellitus	7.3e-05	0.000289	CcSEcCtD
Vardenafil—Headache—Ramipril—type 2 diabetes mellitus	7.26e-05	0.000287	CcSEcCtD
Vardenafil—Nausea—Ramipril—type 2 diabetes mellitus	6.89e-05	0.000272	CcSEcCtD
Vardenafil—PDE11A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.88e-05	0.000132	CbGpPWpGaD
Vardenafil—PDE6G—Disease—EGFR—type 2 diabetes mellitus	1.88e-05	0.000132	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NCOA6—type 2 diabetes mellitus	1.87e-05	0.000131	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.87e-05	0.000131	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.87e-05	0.000131	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.87e-05	0.000131	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.86e-05	0.00013	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IRS1—type 2 diabetes mellitus	1.84e-05	0.000129	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HSD11B1—type 2 diabetes mellitus	1.84e-05	0.000129	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—UCP3—type 2 diabetes mellitus	1.84e-05	0.000129	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—UCP2—type 2 diabetes mellitus	1.84e-05	0.000129	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOS2—type 2 diabetes mellitus	1.78e-05	0.000125	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.78e-05	0.000125	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.77e-05	0.000124	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.76e-05	0.000123	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.75e-05	0.000123	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CASP8—type 2 diabetes mellitus	1.74e-05	0.000122	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PCK1—type 2 diabetes mellitus	1.73e-05	0.000121	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AVP—type 2 diabetes mellitus	1.73e-05	0.000121	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.73e-05	0.000121	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.73e-05	0.000121	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—EGFR—type 2 diabetes mellitus	1.72e-05	0.000121	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.72e-05	0.000121	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.72e-05	0.000121	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.71e-05	0.00012	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AKT2—type 2 diabetes mellitus	1.71e-05	0.00012	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IRS1—type 2 diabetes mellitus	1.7e-05	0.000119	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.7e-05	0.000119	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.69e-05	0.000119	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.68e-05	0.000118	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APOB—type 2 diabetes mellitus	1.67e-05	0.000117	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.67e-05	0.000117	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.66e-05	0.000117	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.64e-05	0.000115	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.64e-05	0.000115	CbGpPWpGaD
Vardenafil—PDE1B—Disease—INS—type 2 diabetes mellitus	1.63e-05	0.000114	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.63e-05	0.000114	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HK1—type 2 diabetes mellitus	1.62e-05	0.000114	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.61e-05	0.000113	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.6e-05	0.000112	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.6e-05	0.000112	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LPL—type 2 diabetes mellitus	1.6e-05	0.000112	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.59e-05	0.000111	CbGpPWpGaD
Vardenafil—PDE1B—Disease—AKT2—type 2 diabetes mellitus	1.58e-05	0.00011	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.57e-05	0.00011	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—KCNJ11—type 2 diabetes mellitus	1.57e-05	0.00011	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GCKR—type 2 diabetes mellitus	1.57e-05	0.00011	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HSD3B2—type 2 diabetes mellitus	1.57e-05	0.00011	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LPA—type 2 diabetes mellitus	1.57e-05	0.00011	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.56e-05	0.000109	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIK3R1—type 2 diabetes mellitus	1.55e-05	0.000109	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.54e-05	0.000108	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALDOB—type 2 diabetes mellitus	1.5e-05	0.000105	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SRC—type 2 diabetes mellitus	1.5e-05	0.000105	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SERPINE1—type 2 diabetes mellitus	1.5e-05	0.000105	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.5e-05	0.000105	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—BCL2—type 2 diabetes mellitus	1.49e-05	0.000105	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.47e-05	0.000103	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.47e-05	0.000103	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.46e-05	0.000102	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.46e-05	0.000102	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—RELA—type 2 diabetes mellitus	1.46e-05	0.000102	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IL6—type 2 diabetes mellitus	1.44e-05	0.000101	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.44e-05	0.000101	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—C3—type 2 diabetes mellitus	1.44e-05	0.000101	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3R1—type 2 diabetes mellitus	1.43e-05	0.0001	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOS3—type 2 diabetes mellitus	1.43e-05	0.0001	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.42e-05	9.98e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.4e-05	9.83e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.4e-05	9.83e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GLP1R—type 2 diabetes mellitus	1.4e-05	9.79e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.37e-05	9.6e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.37e-05	9.57e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AGT—type 2 diabetes mellitus	1.36e-05	9.56e-05	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—AKT1—type 2 diabetes mellitus	1.36e-05	9.52e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.34e-05	9.4e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.34e-05	9.4e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APOE—type 2 diabetes mellitus	1.34e-05	9.37e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LEP—type 2 diabetes mellitus	1.34e-05	9.37e-05	CbGpPWpGaD
Vardenafil—PDE6G—Disease—AKT1—type 2 diabetes mellitus	1.33e-05	9.33e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.33e-05	9.32e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.33e-05	9.32e-05	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IL6—type 2 diabetes mellitus	1.33e-05	9.29e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.32e-05	9.26e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.31e-05	9.21e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTGS2—type 2 diabetes mellitus	1.31e-05	9.17e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.31e-05	9.16e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC2A2—type 2 diabetes mellitus	1.3e-05	9.14e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.28e-05	8.98e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CPT1A—type 2 diabetes mellitus	1.28e-05	8.95e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MTR—type 2 diabetes mellitus	1.28e-05	8.95e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.27e-05	8.89e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.26e-05	8.84e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NAMPT—type 2 diabetes mellitus	1.25e-05	8.78e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LIPC—type 2 diabetes mellitus	1.24e-05	8.72e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HBA1—type 2 diabetes mellitus	1.24e-05	8.72e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GCK—type 2 diabetes mellitus	1.24e-05	8.72e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP11A1—type 2 diabetes mellitus	1.24e-05	8.67e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—NFKB1—type 2 diabetes mellitus	1.23e-05	8.62e-05	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—AKT1—type 2 diabetes mellitus	1.22e-05	8.57e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC9A1—type 2 diabetes mellitus	1.21e-05	8.51e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CETP—type 2 diabetes mellitus	1.2e-05	8.42e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.19e-05	8.36e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.17e-05	8.2e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.17e-05	8.2e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—SRC—type 2 diabetes mellitus	1.15e-05	8.03e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—INS—type 2 diabetes mellitus	1.14e-05	8e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.13e-05	7.92e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.13e-05	7.92e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.13e-05	7.92e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.13e-05	7.92e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.13e-05	7.92e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.12e-05	7.88e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SNAP25—type 2 diabetes mellitus	1.12e-05	7.82e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PSMD6—type 2 diabetes mellitus	1.12e-05	7.82e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SREBF1—type 2 diabetes mellitus	1.12e-05	7.82e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.1e-05	7.74e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.1e-05	7.74e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.1e-05	7.74e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.1e-05	7.7e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CTGF—type 2 diabetes mellitus	1.1e-05	7.68e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.09e-05	7.67e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HMGCR—type 2 diabetes mellitus	1.09e-05	7.61e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ADRA2A—type 2 diabetes mellitus	1.06e-05	7.45e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SRC—type 2 diabetes mellitus	1.06e-05	7.42e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.05e-05	7.35e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.03e-05	7.25e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.03e-05	7.25e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	1.02e-05	7.16e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.02e-05	7.14e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL6—type 2 diabetes mellitus	1.01e-05	7.08e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	1.01e-05	7.08e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	1.01e-05	7.08e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.01e-05	7.06e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—EGFR—type 2 diabetes mellitus	1e-05	7.04e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1e-05	7.02e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	1e-05	7.02e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL6—type 2 diabetes mellitus	9.85e-06	6.9e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	9.85e-06	6.9e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	9.68e-06	6.78e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	9.68e-06	6.78e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	9.61e-06	6.74e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	9.61e-06	6.74e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	9.61e-06	6.74e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TGFB1—type 2 diabetes mellitus	9.46e-06	6.63e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RELA—type 2 diabetes mellitus	9.43e-06	6.61e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.32e-06	6.53e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—EGFR—type 2 diabetes mellitus	9.27e-06	6.5e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	9.21e-06	6.46e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	9.21e-06	6.46e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.08e-06	6.37e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	8.87e-06	6.22e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	8.87e-06	6.22e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	8.71e-06	6.11e-05	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.58e-06	6.02e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	8.57e-06	6e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	8.57e-06	6e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	8.57e-06	6e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.5e-06	5.96e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.45e-06	5.92e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	8.34e-06	5.85e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.34e-06	5.85e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	8.3e-06	5.82e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	8.19e-06	5.74e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	8.05e-06	5.64e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.04e-06	5.63e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	7.95e-06	5.58e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.95e-06	5.57e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.79e-06	5.46e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	7.74e-06	5.42e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL6—type 2 diabetes mellitus	7.72e-06	5.41e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	7.6e-06	5.32e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7.54e-06	5.29e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	7.44e-06	5.21e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	7.41e-06	5.19e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SRC—type 2 diabetes mellitus	7.41e-06	5.19e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	7.28e-06	5.11e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	7.28e-06	5.11e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	7.28e-06	5.11e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	7.28e-06	5.11e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	7.22e-06	5.06e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.22e-06	5.06e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IL6—type 2 diabetes mellitus	7.13e-06	4.99e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	7.13e-06	4.99e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AKT1—type 2 diabetes mellitus	7.12e-06	4.99e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.98e-06	4.89e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	6.84e-06	4.79e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	6.71e-06	4.7e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.62e-06	4.64e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—AKT1—type 2 diabetes mellitus	6.57e-06	4.61e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	6.5e-06	4.55e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.49e-06	4.55e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.49e-06	4.55e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	6.39e-06	4.48e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	6.37e-06	4.46e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	6.29e-06	4.41e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.06e-06	4.25e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.94e-06	4.16e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.94e-06	4.16e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.82e-06	4.08e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.79e-06	4.06e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.79e-06	4.06e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.79e-06	4.06e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.75e-06	4.03e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.65e-06	3.96e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.58e-06	3.91e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	5.55e-06	3.89e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	5.44e-06	3.81e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.19e-06	3.64e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.19e-06	3.64e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.19e-06	3.64e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.09e-06	3.57e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.05e-06	3.54e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6—type 2 diabetes mellitus	4.99e-06	3.5e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	4.99e-06	3.49e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.94e-06	3.46e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	4.77e-06	3.34e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	4.77e-06	3.34e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.75e-06	3.33e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.69e-06	3.29e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.69e-06	3.29e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.6e-06	3.23e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.5e-06	3.15e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.5e-06	3.15e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	4.36e-06	3.06e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.88e-06	2.72e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.88e-06	2.72e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.86e-06	2.71e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.81e-06	2.67e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.7e-06	2.59e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.6e-06	2.52e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.53e-06	2.47e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.46e-06	2.42e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.45e-06	2.41e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.36e-06	2.35e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.31e-06	2.32e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.18e-06	2.23e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.12e-06	2.19e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.02e-06	2.12e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.97e-06	2.08e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.96e-06	2.07e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.93e-06	2.05e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.58e-06	1.81e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.53e-06	1.77e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.32e-06	1.62e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.22e-06	1.55e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.22e-06	1.55e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	2.19e-06	1.54e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.03e-06	1.42e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.02e-06	7.14e-06	CbGpPWpGaD
